Cryo-EM structures of full-length integrin αIIbβ3 in native lipids

Abstract Platelet integrin αIIbβ3 is maintained in a bent inactive state (low affinity to physiologic ligand), but can rapidly switch to a ligand-competent (high-affinity) state in response to intracellular signals (“inside-out” activation). Once bound, ligands drive proadhesive “outside-in” signali...

Full description

Bibliographic Details
Main Authors: Brian D. Adair, Jian-Ping Xiong, Mark Yeager, M. Amin Arnaout
Format: Article
Language:English
Published: Nature Portfolio 2023-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-39763-0
_version_ 1797778785416773632
author Brian D. Adair
Jian-Ping Xiong
Mark Yeager
M. Amin Arnaout
author_facet Brian D. Adair
Jian-Ping Xiong
Mark Yeager
M. Amin Arnaout
author_sort Brian D. Adair
collection DOAJ
description Abstract Platelet integrin αIIbβ3 is maintained in a bent inactive state (low affinity to physiologic ligand), but can rapidly switch to a ligand-competent (high-affinity) state in response to intracellular signals (“inside-out” activation). Once bound, ligands drive proadhesive “outside-in” signaling. Anti-αIIbβ3 drugs like eptifibatide can engage the inactive integrin directly, inhibiting thrombosis but inadvertently impairing αIIbβ3 hemostatic functions. Bidirectional αIIbβ3 signaling is mediated by reorganization of the associated αIIb and β3 transmembrane α-helices, but the underlying changes remain poorly defined absent the structure of the full-length receptor. We now report the cryo-EM structures of full-length αIIbβ3 in its apo and eptifibatide-bound states in native cell-membrane nanoparticles at near-atomic resolution. The apo form adopts the bent inactive state but with separated transmembrane α-helices, and a fully accessible ligand-binding site that challenges the model that this site is occluded by the plasma membrane. Bound eptifibatide triggers dramatic conformational changes that may account for impaired hemostasis. These results advance our understanding of integrin structure and function and may guide development of safer inhibitors.
first_indexed 2024-03-12T23:22:34Z
format Article
id doaj.art-b492d27f5ecf4a52879de123c3081790
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-12T23:22:34Z
publishDate 2023-07-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-b492d27f5ecf4a52879de123c30817902023-07-16T11:22:01ZengNature PortfolioNature Communications2041-17232023-07-011411710.1038/s41467-023-39763-0Cryo-EM structures of full-length integrin αIIbβ3 in native lipidsBrian D. Adair0Jian-Ping Xiong1Mark Yeager2M. Amin Arnaout3Leukocyte Biology and Inflammation Laboratory, Structural Biology Program, Division of Nephrology, Department of Medicine, Massachusetts General HospitalLeukocyte Biology and Inflammation Laboratory, Structural Biology Program, Division of Nephrology, Department of Medicine, Massachusetts General HospitalThe Phillip and Patricia Frost Institute for Chemistry and Molecular Science, University of MiamiLeukocyte Biology and Inflammation Laboratory, Structural Biology Program, Division of Nephrology, Department of Medicine, Massachusetts General HospitalAbstract Platelet integrin αIIbβ3 is maintained in a bent inactive state (low affinity to physiologic ligand), but can rapidly switch to a ligand-competent (high-affinity) state in response to intracellular signals (“inside-out” activation). Once bound, ligands drive proadhesive “outside-in” signaling. Anti-αIIbβ3 drugs like eptifibatide can engage the inactive integrin directly, inhibiting thrombosis but inadvertently impairing αIIbβ3 hemostatic functions. Bidirectional αIIbβ3 signaling is mediated by reorganization of the associated αIIb and β3 transmembrane α-helices, but the underlying changes remain poorly defined absent the structure of the full-length receptor. We now report the cryo-EM structures of full-length αIIbβ3 in its apo and eptifibatide-bound states in native cell-membrane nanoparticles at near-atomic resolution. The apo form adopts the bent inactive state but with separated transmembrane α-helices, and a fully accessible ligand-binding site that challenges the model that this site is occluded by the plasma membrane. Bound eptifibatide triggers dramatic conformational changes that may account for impaired hemostasis. These results advance our understanding of integrin structure and function and may guide development of safer inhibitors.https://doi.org/10.1038/s41467-023-39763-0
spellingShingle Brian D. Adair
Jian-Ping Xiong
Mark Yeager
M. Amin Arnaout
Cryo-EM structures of full-length integrin αIIbβ3 in native lipids
Nature Communications
title Cryo-EM structures of full-length integrin αIIbβ3 in native lipids
title_full Cryo-EM structures of full-length integrin αIIbβ3 in native lipids
title_fullStr Cryo-EM structures of full-length integrin αIIbβ3 in native lipids
title_full_unstemmed Cryo-EM structures of full-length integrin αIIbβ3 in native lipids
title_short Cryo-EM structures of full-length integrin αIIbβ3 in native lipids
title_sort cryo em structures of full length integrin αiibβ3 in native lipids
url https://doi.org/10.1038/s41467-023-39763-0
work_keys_str_mv AT briandadair cryoemstructuresoffulllengthintegrinaiibb3innativelipids
AT jianpingxiong cryoemstructuresoffulllengthintegrinaiibb3innativelipids
AT markyeager cryoemstructuresoffulllengthintegrinaiibb3innativelipids
AT maminarnaout cryoemstructuresoffulllengthintegrinaiibb3innativelipids